MedPath

JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia
Ownership
-
Established
1876-01-01
Employees
19.4K
Market Cap
-
Website
https://www.jhu.edu/

Clinic-based Versus Hotspot-focused Active TB Case Finding

Not Applicable
Recruiting
Conditions
Tuberculosis, Pulmonary
Mycobacterium Tuberculosis Infection
Interventions
Other: Active TB case finding with linkage to preventive therapy (ACF/TPT)
First Posted Date
2022-03-17
Last Posted Date
2024-04-29
Lead Sponsor
Johns Hopkins University
Target Recruit Count
80000
Registration Number
NCT05285202
Locations
🇺🇬

Walimu, Kampala, Uganda

Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone

Phase 2
Recruiting
Conditions
AMCI - Amnestic Mild Cognitive Impairment
Sleep Disturbance
Interventions
Drug: Trazodone
Drug: Placebo
First Posted Date
2022-03-16
Last Posted Date
2024-01-12
Lead Sponsor
Johns Hopkins University
Target Recruit Count
100
Registration Number
NCT05282550
Locations
🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

Trial to Determine Effective Aspirin Dose in COPD

Phase 3
Recruiting
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
First Posted Date
2022-03-03
Last Posted Date
2024-03-19
Lead Sponsor
Johns Hopkins University
Target Recruit Count
48
Registration Number
NCT05265299
Locations
🇺🇸

Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Implementation and Evaluation of a Diabetes Prevention Clinical Pathway in Primary Care

Not Applicable
Completed
Conditions
Prediabetic State
PreDiabetes
Interventions
Other: START diabetes prevention clinical pathway
First Posted Date
2022-03-03
Last Posted Date
2024-06-25
Lead Sponsor
Johns Hopkins University
Target Recruit Count
1910
Registration Number
NCT05265312
Locations
🇺🇸

Johns Hopkins General Internal Medicine clinic at Green Spring Station, Lutherville, Maryland, United States

Immediate Effects of DLPFC tDCS on Attention Bias

Not Applicable
Withdrawn
Conditions
Depression
Interventions
Device: Transcranial direct current stimulation (tDCS)
First Posted Date
2022-03-02
Last Posted Date
2024-04-03
Lead Sponsor
Johns Hopkins University
Registration Number
NCT05263440

Anesthetic Optimization in Pediatric LeFort Surgeries

Not Applicable
Not yet recruiting
Conditions
Pain, Postoperative
Le Fort
Interventions
Other: Standardized Anesthetic Course from Premedication to Induction
First Posted Date
2022-03-02
Last Posted Date
2025-01-10
Lead Sponsor
Johns Hopkins University
Target Recruit Count
50
Registration Number
NCT05260320
Locations
🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

Patient Engagement in Perioperative Pain Management Project

Not Applicable
Completed
Conditions
Opioid Use Disorder
Pain, Postoperative
Interventions
Behavioral: Educational Guide
Behavioral: Patient Engagement Tools
First Posted Date
2022-02-23
Last Posted Date
2024-02-08
Lead Sponsor
Johns Hopkins University
Target Recruit Count
178
Registration Number
NCT05252767
Locations
🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

Phase 3
Recruiting
Conditions
Post-ERCP Acute Pancreatitis
Interventions
First Posted Date
2022-02-23
Last Posted Date
2024-12-18
Lead Sponsor
Johns Hopkins University
Target Recruit Count
4874
Registration Number
NCT05252754
Locations
🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

🇮🇳

Post Graduate Institute of Medical Education and Research, Chandigarh, India

🇮🇳

Apollo Multispecialty Hospitals,, Kolkata, West Bengal, India

and more 2 locations

Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care

Not Applicable
Recruiting
Conditions
Hiv
Alcohol Use, Unspecified
Interventions
Behavioral: Practice Facilitation
Behavioral: Alcohol Stepped Care
First Posted Date
2022-02-16
Last Posted Date
2024-07-10
Lead Sponsor
Johns Hopkins University
Target Recruit Count
300
Registration Number
NCT05241990
Locations
🇺🇸

University of California, San Diego, San Diego, California, United States

🇺🇸

Fenway Community Health, Boston, Massachusetts, United States

🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use

Phase 2
Withdrawn
Conditions
Opioid Use Disorder
Interventions
Drug: Placebo
Drug: Psilocybin
First Posted Date
2022-02-16
Last Posted Date
2024-02-02
Lead Sponsor
Johns Hopkins University
Registration Number
NCT05242029
© Copyright 2025. All Rights Reserved by MedPath